ARCH Venture Partners vs F-Prime Capital Partners
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| ARCH Venture Partners | F-Prime Capital Partners | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Chicago | Cambridge |
| Founded | 1989 | 2002 |
| Check size | $50K – $250M | $3M – $10M |
| Stages | Seed, Series A, Series B, Series C, Growth | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Deep Tech, Healthtech | Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS |
| AUM | $12B | $13B |
| Tracked investments | 144 | 378 |
| Exits (acquired/public) | 6 | 6 |
| Led rounds on record | 3 | — |
| Dated deals, last 24 mo | 10 | 5 |
Shared portfolio · 17
Aera TherapeuticsBeam TherapeuticsDenali TherapeuticsMetseranChroma BioNeumora TherapeuticsPrime MedicineQuantum CircuitsRhyGaze AGSana BiotechnologySingular Genomics SystemsSironaxTenvieVerve TherapeuticsXaira TherapeuticsCurie BioHua Medicine
Frequently asked questions
- Do ARCH Venture Partners and F-Prime Capital Partners invest together?
- Yes — ARCH Venture Partners and F-Prime Capital Partners appear together in 17 tracked portfolio companies, including Aera Therapeutics, Beam Therapeutics, Denali Therapeutics, Metsera, nChroma Bio.
- How do ARCH Venture Partners and F-Prime Capital Partners compare on check size?
- ARCH Venture Partners typically writes checks of $50K – $250M, while F-Prime Capital Partners writes $3M – $10M.